|4Oct 11, 5:00 PM ET

Bernard Thierry 4

4 · T2 Biosystems, Inc. · Filed Oct 11, 2023

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-152,3000 total
    Common Stock (2,300 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-15+2,3007,322 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4